Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Parasitology ; 146(13): 1620-1630, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31397256

RESUMEN

Alveolar echinococcosis is a neglected parasitic zoonosis caused by the metacestode Echinococcus multilocularis, which grows as a malignant tumour-like infection in the liver of humans. Albendazole (ABZ) is the antiparasitic drug of choice for the treatment of the disease. However, its effectiveness is low, due to its poor absorption from the gastro-intestinal tract. It is also parasitostatic and in some cases produces side-effects. Therefore, an alternative to the treatment of this severe human disease is necessary. In this context, the repositioning of drugs combined with nanotechnology to improve the bioavailability of drugs emerges as a useful, fast and inexpensive tool for the treatment of neglected diseases. The in vitro and in vivo efficacy of dichlorophen (DCP), an antiparasitic agent for intestinal parasites, and silica nanoparticles modified with DCP (NP-DCP) was evaluated against E. multilocularis larval stage. Both formulations showed a time and dose-dependent in vitro effect against protoscoleces. The NP-DCP had a greater in vitro efficacy than the drug alone or ABZ. In vivo studies demonstrated that the NP-DCP (4 mg kg-1) had similar efficacy to ABZ (25 mg kg-1) and greater activity than the free DCP. Therefore, the repurposing of DCP combined with silica nanoparticles could be an alternative for the treatment of echinococcosis.


Asunto(s)
Antiparasitarios/uso terapéutico , Diclorofeno/uso terapéutico , Reposicionamiento de Medicamentos , Equinococosis/tratamiento farmacológico , Echinococcus multilocularis/efectos de los fármacos , Dióxido de Silicio/química , Animales , Quimioterapia Combinada , Femenino , Estadios del Ciclo de Vida/efectos de los fármacos , Ratones , Nanopartículas/química , Nanotecnología
2.
3.
J Trop Med Hyg ; 83(2): 71-4, 1980 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7381983

RESUMEN

Niclosamide and Dichlorophen have been tried in infection with F. buski in an endemic area of Bangladesh. Niclosamide is the commonly used agent for this condition, but was found to reduce the ova count by about 48.5% only and repeat treatment did not improve the result. Dichlorophen is advocated for tape worm, but was found to reduce the ova count by 83.3% and repeat treatment completely eradicated infection with F. buski.


Asunto(s)
Diclorofeno/uso terapéutico , Niclosamida/uso terapéutico , Infecciones por Trematodos/tratamiento farmacológico , Adolescente , Niño , Preescolar , Relación Dosis-Respuesta a Droga , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA